All Articles

With AI regulations looming, Seekr hires a top marketer to lead the charge in the high-stakes market for auditable and defensible artificial intelligence.

True crime titans unite as Hunt A Killer and Morbid launch an immersive game, letting fans solve a cold case with physical clues and exclusive audio.

A renewed alliance aims to break key supply chain bottlenecks in gene therapy, offering developers faster access to critical, regulatory-ready materials.

After a multimillion-dollar overhaul, Waikiki's oldest hotel blends 125 years of history with modern luxury and deep-rooted Hawaiian culture.

With a new CEO, Impossible Metals aims to scale its AI robots for ocean mining. But can its 'green' tech win over fierce environmental opposition?

Olaplex posts a Q1 sales gain but a net loss in its last report before its $1.4B acquisition by Henkel, revealing shifting retail dynamics.

A new pavilion at France's Hill 70 Memorial honors a forgotten battle and the Franco-Canadian genius who revolutionized modern warfare for the Allies.

After private rejections, Dream Finders Homes takes its acquisition offer public, putting pressure on Beazer's board amid the rival's financial struggles.

As new rules threaten Medicaid for millions, a health coalition released a blueprint for using AI responsibly. But will states and tech vendors listen?

Amidst domestic housing fears, a major UK asset manager's financing of CMI Financial Group highlights global confidence and the growing power of private credit.

Exploration reveals a multi-kilometer mineralized system at the Tipicancha target, setting the stage for a pivotal drill program amid a global copper crunch.

A new drug targeting the root cause of sebum production shows promise in clinical trials, offering hope for millions of moderate to severe acne sufferers.

OneOdio's new Studio Max 2, tuned by DJ KSHMR, claims a record-breaking 9ms latency. Can it finally cut the cord for professional music production?

A new Space Act Agreement aims to build data centers on the Moon. What does this mean for disaster recovery, the cislunar economy, and humanity's future?

Actuate Therapeutics gets FDA nod for its oral cancer drug elraglusib, shifting strategy to improve patient outcomes and tackle hard-to-treat tumors.

A massive investment in Evolution Metals aims to break China's grip on critical materials, powering US green tech and national security ambitions.

The fashion retailer announces a plan to repurchase 5% of its public shares, flexing its financial muscle after a year of record growth and expansion.

Screendragon's new AI Hub lets marketers build and govern AI agents in their workflows, aiming to solve enterprise issues of control, cost, and compliance.

The Canadian digital media firm moves to repurchase shares and bolster its pension plan, signaling a mature strategy focused on shareholder value and stability.

A new talent intelligence platform offers real-time data, revealing that brand, not salary, is the key to attracting top candidates in the AI era.